Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elnaz Atabakhsh

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|November 3, 2012
RanBPM is an inhibitor of ERK signalingElnaz Atabakhsh, Caroline Schild-Poulter
Molecular Cancer Research : MCR|December 10, 2009
RanBPM has proapoptotic activities that regulate cell death pathways in response to DNA damageElnaz Atabakhsh, Dawn M Bryce, Karen J Lefebvre, et al.
Nature Communications|December 16, 2018
Functional genomic analysis identifies miRNA repertoire regulating C. elegans oocyte developmentAmanda L Minogue, Michael R Tackett, Elnaz Atabakhsh, et al.
American Journal of Cancer Research|September 8, 2012
RanBPM expression regulates transcriptional pathways involved in development and tumorigenesisElnaz Atabakhsh, Jean H Wang, Xu Wang, et al.
Ebiomedicine|January 20, 2022
Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samplesNeus Masqué-Soler, Marcel Gehrung, Cassandra Kosmidou, et al.
International Journal of Toxicology|November 9, 2020
The Utility of Novel Urinary Biomarkers in Mice for Drug Development StudiesAdeyemi O Adedeji, Yi-Zhong Gu, Tony Pourmohamad, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 28, 2020
Urinary miRNA Biomarkers of Drug-Induced Kidney Injury and Their Site Specificity Within the NephronBrian N Chorley, Heidrun Ellinger-Ziegelbauer, Michael Tackett, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2023
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter N Taylor, Kimberly S Collins, Anna Lam, et al.
Genes & Development|May 22, 2015
Hypoxia drives transient site-specific copy gain and drug-resistant gene expressionJoshua C Black, Elnaz Atabakhsh, Jaegil Kim, et al.
Critical Reviews in Toxicology|May 26, 2021
Methodological considerations for measuring biofluid-based microRNA biomarkersBrian N Chorley, Elnaz Atabakhsh, Graeme Doran, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|November 3, 2012
RanBPM is an inhibitor of ERK signalingElnaz Atabakhsh, Caroline Schild-Poulter
Molecular Cancer Research : MCR|December 10, 2009
RanBPM has proapoptotic activities that regulate cell death pathways in response to DNA damageElnaz Atabakhsh, Dawn M Bryce, Karen J Lefebvre, et al.
Nature Communications|December 16, 2018
Functional genomic analysis identifies miRNA repertoire regulating C. elegans oocyte developmentAmanda L Minogue, Michael R Tackett, Elnaz Atabakhsh, et al.
American Journal of Cancer Research|September 8, 2012
RanBPM expression regulates transcriptional pathways involved in development and tumorigenesisElnaz Atabakhsh, Jean H Wang, Xu Wang, et al.
Ebiomedicine|January 20, 2022
Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samplesNeus Masqué-Soler, Marcel Gehrung, Cassandra Kosmidou, et al.
International Journal of Toxicology|November 9, 2020
The Utility of Novel Urinary Biomarkers in Mice for Drug Development StudiesAdeyemi O Adedeji, Yi-Zhong Gu, Tony Pourmohamad, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 28, 2020
Urinary miRNA Biomarkers of Drug-Induced Kidney Injury and Their Site Specificity Within the NephronBrian N Chorley, Heidrun Ellinger-Ziegelbauer, Michael Tackett, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2023
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter N Taylor, Kimberly S Collins, Anna Lam, et al.
Genes & Development|May 22, 2015
Hypoxia drives transient site-specific copy gain and drug-resistant gene expressionJoshua C Black, Elnaz Atabakhsh, Jaegil Kim, et al.
Critical Reviews in Toxicology|May 26, 2021
Methodological considerations for measuring biofluid-based microRNA biomarkersBrian N Chorley, Elnaz Atabakhsh, Graeme Doran, et al.
Pageof 1